Financials data is unavailable for this security.
View more
Year on year Vineet Laboratories Ltd 's revenues fell -50.20% from 1.51bn to 749.95m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 10.27m to a loss of 201.91m.
| Gross margin | 4.86% |
|---|---|
| Net profit margin | -29.27% |
| Operating margin | -24.92% |
| Return on assets | -16.94% |
|---|---|
| Return on equity | -74.23% |
| Return on investment | -54.66% |
More ▼
Cash flow in INRView more
In 2025, Vineet Laboratories Ltd increased its cash reserves by 34.68%, or 790.00k. The company earned 114.91m from its operations for a Cash Flow Margin of 15.32%. In addition the company used 31.82m on investing activities and also paid 82.30m in financing cash flows.
| Cash flow per share | -12.94 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 13.02 |
|---|---|
| Tangible book value per share | 13.02 |
More ▼
Balance sheet in INRView more
| Current ratio | 0.9533 |
|---|---|
| Quick ratio | 0.1186 |
| Total debt/total equity | 3.01 |
|---|---|
| Total debt/total capital | 0.7505 |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items dropped -2,065.82%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -309.77 |
